Abstract
Although advances in graft procurement, preservation, matching and immunosuppression have all contributed to todays outstanding short-term graft survival rates after solid organ transplantation, similar success has not been achieved in preventing chronic transplant dysfunction (CTD) and extending long-term graft survival. CTD is being recognized as one of the major causes of long-term ( > 5 years) graft loss. CTD is featured by obliteration of the vascular lumen as a result of occlusive neointima formation referred to as transplant arteriopathy (TA). Uncontrolled proliferation (hyperplasia) of smooth muscle cells (SMCs) is in major part responsible for neointima formation in TA. Endothelial cells (ECs) cover the neointima and form the barrier between the circulating blood and the vascular wall. The etiology of TA is largely unknown and development of TA is refractory to most anti-rejection therapies. Recent data attribute an important role to host-derived vascular progenitor cells in the development of TA, and these cells may be recruited from various sources including the bone marrow. Vascular progenitor cells are potential targets for therapeutic intervention to attenuate TA development. Therefore, understanding the molecular pathways that promote recruitment of vascular progenitor cells, that determine their differentiation fate, and that determine the proliferative capacity of their progeny, is warranted to dissect their detrimental and possible beneficial effects in the development of TA.
Keywords: Arteriopathy, endothelium, progenitor cell, rejection, smooth muscle, stem cell, transplantation
Current Genomics
Title: Vascular Progenitor Cells in the Development of Transplant Arteriopathy
Volume: 6 Issue: 6
Author(s): J. L. Hillebrands, H. Rienstra, G. Onuta and J. Rozing
Affiliation:
Keywords: Arteriopathy, endothelium, progenitor cell, rejection, smooth muscle, stem cell, transplantation
Abstract: Although advances in graft procurement, preservation, matching and immunosuppression have all contributed to todays outstanding short-term graft survival rates after solid organ transplantation, similar success has not been achieved in preventing chronic transplant dysfunction (CTD) and extending long-term graft survival. CTD is being recognized as one of the major causes of long-term ( > 5 years) graft loss. CTD is featured by obliteration of the vascular lumen as a result of occlusive neointima formation referred to as transplant arteriopathy (TA). Uncontrolled proliferation (hyperplasia) of smooth muscle cells (SMCs) is in major part responsible for neointima formation in TA. Endothelial cells (ECs) cover the neointima and form the barrier between the circulating blood and the vascular wall. The etiology of TA is largely unknown and development of TA is refractory to most anti-rejection therapies. Recent data attribute an important role to host-derived vascular progenitor cells in the development of TA, and these cells may be recruited from various sources including the bone marrow. Vascular progenitor cells are potential targets for therapeutic intervention to attenuate TA development. Therefore, understanding the molecular pathways that promote recruitment of vascular progenitor cells, that determine their differentiation fate, and that determine the proliferative capacity of their progeny, is warranted to dissect their detrimental and possible beneficial effects in the development of TA.
Export Options
About this article
Cite this article as:
Hillebrands L. J., Rienstra H., Onuta G. and Rozing J., Vascular Progenitor Cells in the Development of Transplant Arteriopathy, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774483007
DOI https://dx.doi.org/10.2174/138920205774483007 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patent Selections
Recent Patents on Cardiovascular Drug Discovery Anesthetic Pharmacology and Perioperative Considerations for the End Stage Liver Disease Patient
Current Clinical Pharmacology The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets
Current Pharmaceutical Design Proteomics to Identify Novel Biomarkers and Therapeutic Targets in Cardiovascular Disease
Letters in Drug Design & Discovery Intestinal Permeability as a Clinical Surrogate Endpoint in the Development of Future Crohn's Disease Therapies
Recent Patents on Inflammation & Allergy Drug Discovery Editorial : (Thematic issue: Critical Appraisal of Ischemic Stroke Pathophysiology: Road to Cerebral Resuscitation? Part II)
Current Medicinal Chemistry Noscapine and its Analogs as Chemotherapeutic Agent: Current updates
Current Topics in Medicinal Chemistry Novel Drug Targets for the Treatment of Cardiac Diseases
Current Pharmacogenomics and Personalized Medicine Protective Role of Melatonin in Liver Damage
Current Pharmaceutical Design Myocardial Structure and Matrix Metalloproteinases
Current Topics in Medicinal Chemistry Stem Cells as a Novel Tool for Drug Screening and Treatment of Degenerative Diseases
Current Pharmaceutical Design Minocycline and Cytoprotection: Shedding New Light on a Shadowy Controversy
Current Drug Delivery Adenosine A2A Receptor Antagonists and Parkinsons Disease: State of the Art and Future Directions
Current Pharmaceutical Design Cross-Talk Between NO Synthase Isoforms in Neuro-Inflammation: Possible Implications in HIV-Associated Neurocognitive Disorders
Current Medicinal Chemistry Coated with Nanomaterials Intraocular Lenses, Ophthalmic and Human Body Implantable Devices with High Catalytic Antioxidant Activities: A New Nanotechnology Strategy of Peroxidase Cellular Enzyme Mimics Increasing the Biocompatibility and Therapeutic Deployment of the Medical Prosthetic Device
Recent Patents on Drug Delivery & Formulation Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous System
Recent Patents on CNS Drug Discovery (Discontinued) Inflammatory Markers in Coronary Artery Disease: Pathophysiological Mechanisms, Prognostic and Therapeutic Implications
Current Cardiology Reviews Cerebrovascular Ultrasonography for Selecting Patients for Stroke Intervention
Recent Patents on CNS Drug Discovery (Discontinued) Blood Brain Barrier in Hypoxic-Ischemic Conditions
Current Neurovascular Research Angiogenesis-regulating microRNAs and Ischemic Stroke
Current Vascular Pharmacology